Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2025 18:44 ET | Source: Shamis & Gentile, P.A.

Shamis & Gentile, P.A. Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of agilon health, inc. – AGL

Shamis Gentile is investigating potential breaches of fiduciary duties by the directors and officers of agilon health, inc. -- AGL
November 05, 2025 17:28 ET | Source: Shamis & Gentile, P.A.

Shamis & Gentile, P.A. Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Vestis Corporation -- VSTS

Shamis Gentile Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Vestis -- VSTS
November 04, 2025 16:25 ET | Source: Shamis & Gentile, P.A.

Shamis & Gentile, P.A. Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Live Nation Entertainment, Inc. -- LYV

Shamis & Gentile Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Live Nation Entertainment
November 04, 2025 08:55 ET | Source: Shamis & Gentile, P.A.

Shamis & Gentile, P.A. Is Investigating Shareholder Claims Against Zillow Group, Inc. Directors and Officers for Breach of Fiduciary Duty

The Law Firm of Shamis & Gentile Is Investigating Potential Shareholder Claims Against Zillow Group Directors and Officers
October 23, 2025 08:55 ET | Source: Shamis & Gentile, P.A.

Shamis & Gentile, P.A. has Filed an Expanded Securities Class Action Lawsuit Against aTyr Pharma, Inc. (ATYR) and Alerts Investors of the December 8, 2025 Lead Plaintiff Deadline

Shamis Gentile notifies ATYR investors of an expanded securities class action complaint filed against aTyr Pharma, Inc.
October 10, 2025 12:18 ET | Source: Shamis & Gentile, P.A.

aTyr Pharma, Inc. (ATYR) Securities Class Action Deadline Alert: Shamis & Gentile, P.A. Alerts Investors of Important Lead Plaintiff Deadline of December 8, 2025

Shamis & Gentile, P.A. Alerts Investors of December 8, 2025 Lead Plaintiff Deadline for aTyr Pharma, Inc. (ATYR) Securities Class Action
October 01, 2025 19:47 ET | Source: Shamis & Gentile, P.A.

Shareholder Alert: Shamis & Gentile, P.A. Issues Corrected Notice to Clarify Deadline To Seek Appointment As Lead Plaintiff In Securities Class Action Against Charter Communications, Inc. (Nasdaq:CHTR)

MIAMI, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Shamis & Gentile, P.A, (“Shamis & Gentile”) issues this corrected notice to clarify the deadline to seek appointment as Lead Plaintiff in the...
September 17, 2025 15:44 ET | Source: Shamis & Gentile, P.A.

Shamis & Gentile, P.A. Investigates Claims on Behalf of Investors of Coherent Corp. Securities (COHR)

Shamis & Gentile, P.A. Is Investigating Claims on Behalf of Investors of Coherent Corp. Securities
September 17, 2025 11:36 ET | Source: Shamis & Gentile, P.A.

Luminar Technologies, Inc. Deadline Reminder: Shamis & Gentile, P.A. Reminds Investors of Important Lead Plaintiff Deadline on September 22, 2025.

Shamis & Gentile, P.A. Reminds Luminar Technologies, Inc. Investors of Important Lead Plaintiff Deadline on September 22, 2025.
August 15, 2025 12:00 ET | Source: Shamis & Gentile, P.A.

Shamis & Gentile, P.A. Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Investors in Charter Communications, Inc. Securities and Options, and Sets a Lead Plaintiff Deadline of October 13, 2025

Shamis Gentile notifies investors a securities fraud class action has been filed on behalf of securities and options investors in Charter Communications.